(19)
(11) EP 3 362 051 A1

(12)

(43) Date of publication:
22.08.2018 Bulletin 2018/34

(21) Application number: 16779109.4

(22) Date of filing: 11.10.2016
(51) International Patent Classification (IPC): 
A61K 9/14(2006.01)
A61K 9/20(2006.01)
 A61K 9/16(2006.01)
A61K 31/517(2006.01)
(86) International application number:
PCT/EP2016/074299
(87) International publication number:
WO 2017/064039 (20.04.2017 Gazette 2017/16)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
MA MD

(30) Priority: 12.10.2015 WO PCT/EP2015/189380

(71) Applicant: Sandoz AG
4056 Basel (CH)

(72) Inventors:
  • PELIPENKO, Jan
    1526 Ljubljana (SI)
  • KRISTAN, Katja
    1526 Ljubljana (SI)
  • OBLAK, Marko
    1526 Ljubljana (SI)
  • HOMAR, Miha
    1526 Ljubljana (SI)
  • GRAHEK, Rok
    1526 Ljubljana (SI)

(74) Representative: Kluschanzoff, Harald et al
Sandoz International GmbH Global Intellectual Property Industriestrasse 25
83607 Holzkirchen
83607 Holzkirchen (DE)

   


(54) AFATINIB-CONTAINING FORMULATION